Benzgalantamine
Medication From Wikipedia, the free encyclopedia
Medication From Wikipedia, the free encyclopedia
Benzgalantamine, sold under the brand name Zunveyl, is a medication used for the treatment of mild to moderate dementia of the Alzheimer's type.[1] It is a cholinesterase inhibitor.[1] Benzgalantamine is a prodrug of galantamine.[1]
Clinical data | |
---|---|
Trade names | Zunveyl |
Other names | ALPHA-1062 |
AHFS/Drugs.com | Zunveyl |
License data | |
Routes of administration | By mouth |
Drug class | Cholinesterase inhibitor |
ATC code |
|
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
DrugBank | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C24H25NO4 |
Molar mass | 391.467 g·mol−1 |
3D model (JSmol) | |
| |
|
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Benzgalantamine was approved for medical use in the United States in July 2024.[1][2][3]
Benzgalantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.[1][2]
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Benzgalantamine was approved for medical use in the United States in July 2024.[1][2]
Benzgalantamine is the international nonproprietary name.[4]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.